International Biotechnology (LON:IBT – Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX (4.83) earnings per share (EPS) for the quarter, Digital Look Earnings reports. International Biotechnology had a negative net margin of 6.26% and a negative return on equity of 0.45%. The firm had revenue of GBX 24 million for the quarter.
International Biotechnology Trading Up 0.4%
IBT opened at GBX 980 on Wednesday. The company’s 50 day moving average is GBX 932.43 and its 200 day moving average is GBX 929.26. The company has a market cap of £311.91 million, a price-to-earnings ratio of -297.87 and a beta of 0.49. International Biotechnology has a 12-month low of GBX 546 and a 12-month high of GBX 1,010.
International Biotechnology Company Profile
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Read More
- Five stocks we like better than International Biotechnology
- A Real Biggie Deal: Wendy’s Serves Up a Juicy Buyout Arbitrage
- Ally Financial Is Back to Basics—And Investors Are Watching
- Navitas Breaks Out on India Deal, Validating High-Power AI Pivot
- Navy Catalyst Ignites Odysight’s Growth Engine
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
